Literature DB >> 25892229

SF3B1 association with chromatin determines splicing outcomes.

Nir Kfir1, Galit Lev-Maor1, Ohad Glaich1, Adi Alajem2, Arnab Datta3, Siu K Sze3, Eran Meshorer4, Gil Ast5.   

Abstract

Much remains unknown concerning the mechanism by which the splicing machinery pinpoints short exons within intronic sequences and how splicing factors are directed to their pre-mRNA targets. One probable explanation lies in differences in chromatin organization between exons and introns. Proteomic, co-immunoprecipitation, and sedimentation analyses described here indicate that SF3B1, an essential splicing component of the U2 snRNP complex, is strongly associated with nucleosomes. ChIP-seq and RNA-seq analyses reveal that SF3B1 specifically binds nucleosomes located at exonic positions. SF3B1 binding is enriched at nucleosomes positioned over short exons flanked by long introns that are also characterized by differential GC content between exons and introns. Disruption of SF3B1 binding to such nucleosomes affects splicing of these exons similarly to SF3B1 knockdown. Our findings suggest that the association of SF3B1 with nucleosomes is functionally important for splice-site recognition and that SF3B1 conveys splicing-relevant information embedded in chromatin structure.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25892229     DOI: 10.1016/j.celrep.2015.03.048

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  52 in total

Review 1.  Epigenetics in myelodysplastic syndromes.

Authors:  Michael Heuser; Haiyang Yun; Felicitas Thol
Journal:  Semin Cancer Biol       Date:  2017-08-02       Impact factor: 15.707

Review 2.  The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.

Authors:  Elisabeth Daguenet; Gwendal Dujardin; Juan Valcárcel
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

3.  Evidence that C9ORF72 Dipeptide Repeat Proteins Associate with U2 snRNP to Cause Mis-splicing in ALS/FTD Patients.

Authors:  Shanye Yin; Rodrigo Lopez-Gonzalez; Ryan C Kunz; Jaya Gangopadhyay; Carl Borufka; Steven P Gygi; Fen-Biao Gao; Robin Reed
Journal:  Cell Rep       Date:  2017-06-13       Impact factor: 9.423

Review 4.  Nascent RNA and the Coordination of Splicing with Transcription.

Authors:  Karla M Neugebauer
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-08-01       Impact factor: 10.005

5.  PHF13: A new player involved in RNA polymerase II transcriptional regulation and co-transcriptional splicing.

Authors:  Alisa Fuchs; Marcos Torroba; Sarah Kinkley
Journal:  Transcription       Date:  2017-01-19

Review 6.  Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures.

Authors:  Jermaine L Jenkins; Clara L Kielkopf
Journal:  Trends Genet       Date:  2017-03-31       Impact factor: 11.639

Review 7.  How do messenger RNA splicing alterations drive myelodysplasia?

Authors:  Poorval Joshi; Stephanie Halene; Omar Abdel-Wahab
Journal:  Blood       Date:  2017-03-27       Impact factor: 22.113

8.  Modeling SF3B1 Mutations in Cancer: Advances, Challenges, and Opportunities.

Authors:  Daichi Inoue; Omar Abdel-Wahab
Journal:  Cancer Cell       Date:  2016-09-12       Impact factor: 31.743

Review 9.  Splicing factor gene mutations in hematologic malignancies.

Authors:  Borja Saez; Matthew J Walter; Timothy A Graubert
Journal:  Blood       Date:  2016-12-09       Impact factor: 22.113

Review 10.  Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities.

Authors:  Maxime Blijlevens; Jing Li; Victor W van Beusechem
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.